The structure of a key enzyme for infectious diseases solved at ESRFAugust 12, 2003A European team of scientists from the University of Dundee (UK), the Technical University of Munich (Germany) and the European Synchrotron Radiation Facility, ESRF, (France) have determined the structure of a key target enzyme for novel drug development to treat infectious diseases including malaria, tuberculosis and sexually transmitted bacterial infections. The results of their collaboration are published on the August 5 issue of Proceedings of the National Academy of Sciences. Synchrotron radiation at the ESRF played a key role in the determination of the structure of the enzyme CDP-ME kinase. The experiment took place on one of the macromolecular crystallography beamlines at the ESRF. This kinase helps to produce many of the molecules that bacteria and parasites need to live and multiply. A molecule that can prevent the kinase from working normally will poison and kill the pathogenic organisms. The determination of the structure of the enzyme provides a template for the design of small molecules that will inhibit its action and prevent it from working normally. In the future, the structure may help lead to the development of new potent therapies for a wide range of microbial infections. "These drugs could potentially help the treatment of not only malaria and tuberculosis but also toxoplasmosis, chlamydia, meningitis and cholera for example", explains Professor Bill Hunter, one of the authors of the article. About the technique Protein crystallography consists of the production of highly pure protein samples. These samples are then crystallised to produce single crystals of the protein. When X-rays interact with single crystals, the interaction between the constituents of the crystal and the X-rays results in the production of an interference pattern - known as a diffraction pattern. By the use of suitable physical and chemical techniques it is possible to use the diffraction patterns in order to determine the spatial distribution of the electrons within the crystal sample. The chemical interpretation of this produces the structural model that reveals the three-dimensional structure of the protein. The ESRF presents substantial improvements for the exploitation of this technique; in particular the use of intense, highly collimated X-ray beams greatly aids the investigation of small weakly diffracting crystals. | |||||||||||||||||||||
|
Related Malaria News Articles Study: Delaying evolution of drug resistance in malaria parasite possible There's no magic bullet for wiping out malaria, but a new study offers strong support for a method that effectively delays the evolution of drug resistance in malaria parasites, a University of Florida researcher says. Study: DNA barcoding in danger of 'ringing up' wrong species DNA barcoding is a movement to catalog all life on earth by a simple standardized genetic tag, similar to stores labeling products with unique barcodes. The effort promises foolproof food inspection, improved border security, and better defenses against disease-causing insects, among many other applications. Malaria researchers identify new mosquito virus Researchers at the Johns Hopkins Bloomberg School of Public Health's Malaria Research Institute have identified a previously unknown virus that is infectious to Anopheles gambiae-the mosquito primarily responsible for transmitting malaria. New method to overcome multiple drug resistant diseases developed by Stanford researchers Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them. Johns Hopkins scientists discover what drives the development of a fatal form of malaria Platelets - those tiny, unassuming cells that cause blood to clot and scabs to form when you cut yourself - play an important early role in promoting cerebral malaria, an often lethal complication that occurs mostly in children. Ben-Gurion University of the Negev initiates project to eliminate intestinal worms in Ethiopia A professor at The Faculty of Health Sciences at Ben-Gurion University of the Negev (BGU) is beginning an intensive program in Ethiopia this August to eradicate intestinal worms which affect as much as 50 percent of the population in Africa. Research exposes new target for malaria drugs The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development. Key to virulence protein entry into host cells discovered Researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have identified the region of a large family of virulence proteins in oomycete plant pathogens that enables the proteins to enter the cells of their hosts. U of M researchers find cerebral malaria may be a major cause of brain injury in African children Researchers at the University of Minnesota have found that cerebral malaria is related to long-term cognitive impairment in one of four child survivors. The research is published in the current issue of the journal Pediatrics. Caltech bioengineers develop 'microscope on a chip' Researchers at the California Institute of Technology have turned science fiction into reality with their development of a super-compact high-resolution microscope, small enough to fit on a finger tip. More Malaria News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||